Crossmark

Commentary on “Comparison of Survival Outcomes in Transarterial Ethanol Ablation and Liver Resection for Solitary Hepatocellular Carcinoma ≤ 5 cm in Patients Stratified by Liver Function”

Crossref DOI link: https://doi.org/10.1007/s00270-021-03006-w

Published Online: 2022-01-19

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Ken https://orcid.org/0000-0003-2683-1171
Sofocleous, Constantinos T.

Yarmohammadi, Hooman
License Information

Text and Data Mining valid from 2022-01-19

Version of Record valid from 2022-01-19
More Information

Article History

Received: 27 October 2021

Accepted: 2 November 2021

First Online: 19 January 2022

Declarations

:

: Dr. Yarmohammadi received research grants from the Thompson Foundation and Guerbet. Dr. Sofocleous received consulting fees from Terumo and Varian and consulting fees and research funding from BTG/Boston Scientific, SIRTEX, and Johnson and Johnson. Dr. Zhao has no disclosures.

: For this type of article, ethical approval is not required.

: For this type of article, informed consent is not required.

: For this type of article, consent for publication is not required.

Document is current

Any future updates will be listed below